Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine
Abstract Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter ge...
Guardado en:
Autores principales: | Wook-Jin Park, Yeon-Kyung Yoon, Ji-Sun Park, Ruchirkumar Pansuriya, Yeong-Jae Seok, Ravi Ganapathy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d37cb8763e54effbd1aef2e4478cbac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioinformatic prediction of polymerase elements in the rotavirus VP1 protein
por: VÁSQUEZ-DEL CARPIÓ,RODRIGO, et al.
Publicado: (2006) -
DEVELOPMENT OF FUSION RECOMBINANT PROTEINS BASED ON VP6 AND VP8 OF HUMAN ROTAVIRUS A
por: I. V. Dukhovlinov, et al.
Publicado: (2014) -
PROTECTIVE ACTIVITY STUDY OF A CANDIDATE VACCINE AGAINST ROTAVIRUS INFECTION BASED ON RECOMBINANT PROTEIN FliCVP6VP8
por: I. V. Dukhovlinov, et al.
Publicado: (2016) -
Differences in the amino acid composition of the antigen epitopes of the VP7 protein of Russian rotaviruses with the G9 genotype and the vaccine strains RotaTeq, Rotavac, and Rotarix
por: O. V. Morozova, et al.
Publicado: (2019) -
Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein
por: Bugli F, et al.
Publicado: (2014)